Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging

Journal of Pineal Research

Volumn 49, Issue 3, 2010, Pages 312-320

  Forman, Katherine ^a   Vara, Elena ^a   García, Cruz ^a   Kireev, Roman ^a   Cuesta, Sara ^a   Acuña Castroviejo, Darío ^b   Tresguerres, J A F ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

aging; apoptosis; heart; inflammation; melatonin; oxidative stress

Indexed keywords

DRINKING WATER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE 1; HEME OXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; MELATONIN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOVASCULAR INFLAMMATION; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; DRUG MEGADOSE; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; SENESCENCE; SENESCENCE ACCELERATED MOUSE;

AGING; ANIMALS; ANTIOXIDANTS; APOPTOSIS; DISEASE MODELS, ANIMAL; HEART; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; INTERLEUKIN-1; MALE; MELATONIN; MICE; NF-KAPPA B P50 SUBUNIT; NF-KAPPA B P52 SUBUNIT; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956337711     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00800.x     Document Type: Article

References (75)

1. Lakatta E. Cardiovascular ageing in health sets the stage for cardiovascular disease. Heart Lung Circ 2002 11 : 76 91.
2. Li S, Du M, Dolence EK et al. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification. Aging Cell 2005 4 : 57 64.
3. Maeso R, De Las Heras N, Navarro-Cid J. Alteraciones endoteliales en el envejecimiento. Nefrología 1999 XIX : S35 S45.
4. Matz RL, Scott C, Stoclet C et al. Age related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxigenase products. Physiol Res 2000 49 : 11 18.
5. Zhang Y, Herman B. Apoptosis and successful aging. Mech Ageing Dev 2002 123 : 563 565.
6. Chung HY, Kim HJ, Kim KW et al. Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc Res Tech 2002 59 : 264 272.
7. Rodríguez MI, Carretero M, Escames G et al. Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence-accelerated mice. Free Radic Res 2007 41 : 15 24.
8. Baeza I, Alvarado C, Alvarez P et al. Improvement of leucocyte functions in ovariectomised aged rats after treatment with growth hormone, melatonin, oestrogens or phyto-oestrogens. J Reprod Immunol 2009 80 : 70 79.
9. Sack RL, Lewy AJ, Erb DL et al. Human melatonin production decreases with age. J Pineal Res 1986 3 : 379 388.
10. Reiter RJ, Richardson BA, Johnson LY et al. Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science 1980 210 : 1372 1373.
11. Castillo C, Cruzado M, Ariznavarreta C et al. Effects of ovariectomy and growth hormone administration on body composition and vascular function and structure in old female rats. Biogerontology 2005 6 : 49 60.
12. Wickens AP. Ageing and the free radical theory. Respir Physiol 2001 128 : 379 391.
13. Kireev RA, Tresguerres AC, García C et al. Melatonin is able to prevent the liver of old castrated female rats from oxidative and pro-inflammatory damage. J Pineal Res 2008 45 : 394 402.
14. Pollack M, Phaneuf S, Dirks A et al. The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann N Y Acad Sci 2002 959 : 93 107.
15. Forman K, Vara E, García C et al. Cardiological aging in SAM model: effect of chronic treatment with growth hormone. Biogerontology 2010 11 : 275 286.
16. Tresguerres JAF, Kireev RA, Tresguerres ACF et al. Molecular mechanisms involved in the hormonal prevention of aging in the rat. J Steroid Biochem Mol Biol 2008 108 : 318 326.
17. Kireev RA, Tresguerres AF, Vara E et al. Effect of chronic treatments with GH, melatonin, estrogens, and phytoestrogens on oxidative stress parameters in liver from aged female rats. Biogerontology 2007 8 : 469 482.
18. Ito Y, Betsuyaku T, Moriyama C et al. Aging affects lipopolysaccharide- induced upregulation of heme oxygenase-1 in the lungs and alveolar macrophages. Biogerontology 2009 10 : 173 180.
19. Csiszar A, Wang M, Lakatta E et al. Inflammation and endothelial dysfunction during aging: role of NF-Kb. J Appl Physiol 2008 105 : 1333 1341.
20. Blackwell KA, Sorenson JP, Richardson DM et al. Mechanisms of aging-induced impairment of endothelium dependent relaxation: role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 2004 287 : H2448 H2453.
21. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000 87 : 840 844.
22. Gustafsson AB, Gottlieb RA. Mechanisms of apoptosis in the heart. J Clin Immunol 2003 23 : 447 459.
23. Kumar D, Jugdutt BI. Apoptosis and oxidants in the heart. J Lab Clin Med 2003 142 : 288 297.
24. Jarzynka MJ, Passey DK, Johnson DA et al. Microtubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence. J Pineal Res 2009 46 : 161 171.
25. Simko F, Pechanova O. Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment. J Pineal Res 2009 47 : 127 133.
26. Reiter RJ, Tan DX, Manchester LC et al. Melatonin and reproduction revisited. Biol Reprod 2009 81 : 445 456.
27. Rodríguez MI, Escames G, López LC et al. Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence- accelerated mice. J Pineal Res 2007 42 : 272 279.
28. Cos S, Fernández R, Güézmes A et al. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998 58 : 4383 4390.
29. Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008 45 : 235 246.
30. Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009 47 : 109 126.
31. Pozo D, Reiter RJ, Calvo JR et al. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997 65 : 430 442.
32. Takeda T. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research. Neurobiol Aging 1999 20 : 105 110.
33. Kurokawa T, Osaki N, Ishibashi S. Difference between senescence- accelerated prone and resistant mice in response to insulin in the heart. Mech Ageing Dev 1998 102 : 25 32.
34. Gutierrez-Cuesta J, Sureda FX, Romeu M et al. Chronic administration of melatonin reduces cerebral injury biomarkers in SAMP8. J Pineal Res 2007 42 : 394 402.
35. Butterfield DA, Poon HF. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp Gerontol 2005 40 : 774 783.
36. Lloréns S, De Mera RM, Pascual A et al. The senescence-accelerated mouse (SAM-P8) as a model for the study of vascular functional alterations during aging. Biogerontology 2007 8 : 663 672.
37. Flood JF, Morley JE. Early onset of age-related impairment of aversive and appetitive learning in the SAM-P/8 mouse. J Gerontol 1992 47 : B52 B59.
38. Flood JF, Morley JE, La Reginna M. Age-related changes in the pharmacological improvement of retention in senescence accelerated mouse (SAM). Neurobiol Aging 1993 14 : 159 166.
39. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 162 : 156 159.
40. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001 25 : 402 408.
41. Hosokawa M. A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice. Mech Ageing Dev 2002 123 : 1553 1561.
42. Brown MD. Endothelial ageing: molecular mechanisms and functional significance. Exp Physiol 2009 94 : 297 298.
43. Helenius M, Kyrylenko S, Vehviläinen P et al. Characterization of aging-associated up-regulation of constitutive nuclear factor-kappa B binding activity. Antioxid Redox Signal 2001 3 : 147 156.
44. Hoppel CL, Moghaddas S, Lesnefsky EJ. Interfibrillar cardiac mitochondrial comples III defects in the aging rat heart. Biogerontology 2002 3 : 41 44.
45. Seta F, Bellner L, Rezzani R et al. Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am J Pathol 2006 169 : 1612 1623.
46. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005 39 : 1 25.
47. Morse D, Choi AM. Heme oxygenase-1: the "emerging molecule" has arrived. Am J Respir Cell Mol Biol 2002 27 : 8 16.
48. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006 86 : 583 650.
49. Stoclet JC, Muller B, György K et al. The inducible nitric oxide synthase in vascular and cardiac tissue. Eur J Pharmacol 1999 375 : 139 155.
50. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 2007 42 : 271 279.
51. Smith AR, Visioli F, Frei B et al. Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A. Aging Cell 2006 5 : 391 400.
52. Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989 58 : 227 229.
53. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001 38 : 307 314.
54. Kaltschmidt B, Kaltschmidt C, Hofmann TG et al. The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur J Biochem 2000 267 : 3828 3835.
55. Helenius M, Hänninen M, Lehtinen SK et al. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle. J Mol Cell Cardiol 1996 28 : 487 498.
56. Helenius M, Hänninen M, Lehtinen SK et al. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kB. Biochem J 1996 318 : 603 608.
57. Korhonen P, Helenius M, Salminen A. Age-related changes in the regulation of transcription factor NF-kappa B in rat brain. Neurosci Lett 1997 225 : 61 64.
58. Kireev RA, Tresguerres AC, Garcia C et al. Hormonal regulation of pro-inflammatory and lipid peroxidation processes in liver of old ovariectomized female rats. Biogerontology 2010 11 : 229 243.
59. Tha KK, Okuma Y, Miyazaki H et al. Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res 2000 885 : 25 31.
60. Gustafsson AB, Gottlieb RA. Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 2007 292 : C45 C51.
61. Aggarwal BB. Apoptosis and nuclear factor-kB: a tale of association and dissociation. Biochem Pharmacol 2000 60 : 1033 1039.
62. Brüne B, Von Knethen A, Sandau KB. Nitric oxide and its role in apoptosis. Eur J Pharmacol 1998 351 : 261 272.
63. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology 2000 7 : 153 163.
64. Caballero B, Vega-Naredo I, Sierra V et al. Melatonin alters cell death processes in response to age-related oxidative stress in the brain of senescence-accelerated mice. J Pineal Res 2009 46 : 106 114.
65. Martinez-Cruz F, Espinar A, Pozo D et al. Melatonin prevents focal rat cerebellum injury as assessed by induction of heat shock protein (HO-1) following subarachnoid injections of lysed blood. Neurosci Lett 2002 331 : 208 210.
66. Tengattini S, Reiter RJ, Tan DX et al. Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008 44 : 16 25.
67. Hoyos M, Guerreros JM, Perez-Cano R et al. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats. J Pineal Res 2000 28 : 150 155.
68. Cavallo A, Daniels SR, Dolan LM et al. Blood pressure response to melatonin in type 1 diabetes. Pediatr Diabetes 2004 5 : 26 31.
69. Cagnacci A, Arangino S, Angiolucci M et al. Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy. Clin Endocrinol (Oxf) 2001 54 : 261 266.
70. Bruck R, Aeed H, Avni Y et al. Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats. J Hepatol 2004 40 : 86 93.
71. Chetsawang B, Putthaprasart C, Phansuwan-Pujito P et al. Melatonin protects against hydrogen peroxide-induced cell death signaling in SH-SY5Y cultured cells: involvement of nuclear factor kappa B, Bax and Bcl-2. J Pineal Res 2006 41 : 116 123.
72. Ekmekcioglu C, Haslmayer P, Philipp C et al. Expression of the MT1 melatonin receptor subtype in human coronary arteries. J Recept Signal Transduct Res 2001 21 : 85 91.
73. Ekmekcioglu C, Thalhammer T, Humpeler S et al. The melatonin receptor subtype MT2 is present in the human cardiovascular system. J Pineal Res 2003 35 : 40 44.
74. Masana MI, Doolen S, Ersahin C et al. MT(2) melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 2002 302 : 1295 1302.
75. Erşahin C, Masana MI, Dubocovich ML. Constitutively active melatonin MT(1) receptors in male rat caudal arteries. Eur J Pharmacol 2002 439 : 171 172.